Company Maintains Quarterly Revenues in Challenging Marketplace
NEW YORK, August 15 /PRNewswire-FirstCall/ -- SPO Medical Inc. (OTC: SPOM - News), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced its second quarter results for the period ended June 30, 2008.
Gross revenues for the period were US$1,089,000, a 1% increase over first quarter 2008 gross revenues. The Company maintained consistent gross revenue levels despite the challenging worldwide economic environment, particularly in its primary U.S. homecare market.
During the second quarter, the Company released its PulseOx 7500(TM) supporting GUI (graphic user interface) and report generation in multiple languages including French, Italian, German and Spanish ("FIGS") along with English. Additionally, the Company announced it had initiated field trials for its latest homecare wellness product using SPO's patented technology and creating a new application for the traditional home baby monitor market.
Michael Braunold, President and Chief Executive Officer of SPO Medical commented, "Despite a less than favorable macro-economic climate, we continue to introduce new products into the marketplace while expanding the distribution of our existing product line. Last quarter we were excited to announce our foray into the professional healthcare market with the introduction of two new products, the PulseOx 6000(TM) and PulseOx 6100(TM). We are pleased to report during the second quarter we witnessed an increase in sales and distribution for these new products " Mr. Braunold continued, "Additionally, the release of the enhanced PulseOx 7500(TM) supporting FIGS report generation has been received well by our European distributors."
A more detailed description of the financial results and financial statements are contained in the Company's most recent Quarterly Report on Form 10-QSB filed with the SEC.
|SOURCE SPO Medical Inc.|
Copyright©2008 PR Newswire.
All rights reserved